United States · Federal contract register · Supplier record

GRIFOLS THERAPEUTICS LLC

Line: Drugs and biologicals (6505)Register loaded to November 2025Compiled 6 October 2026

GRIFOLS THERAPEUTICS LLC — United States · Federal contract register · Supplier record: 890 contracts, all years ($27,695,327 · Nov 2012 – Sep 2024); $613K since January 2024 (1 contract · 1 agency); — rank in the line (of 514 suppliers · 0.0%); 8 agencies never served ($52.0M on the line without GRIFOLS THERAPEUTICS LLC).

Assay record ASY-US-04XAENA0JZ · Cite as: Assay Systems, “GRIFOLS THERAPEUTICS LLC in the USAspending register”, https://assay-systems.com/register/us/grifols-therapeutics-llc/

890
contracts, all years
$27,695,327 · Nov 2012 – Sep 2024
$613K
since January 2024
1 contract · 1 agency
—
rank in the line
of 514 suppliers · 0.0%
8
agencies never served
$52.0M on the line without GRIFOLS THERAPEUTICS LLC

Own record by year

2019 onward
$1.2M
$994K
$585K
$100K
$613K
2019202020212022202320242025

Who buys from GRIFOLS THERAPEUTICS LLC

since January 2024
1agencies
$613Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$613,200

Before 2024 only: Department of Defense, Department of Justice, Department of Veterans Affairs.

The line

since January 2024
$28.2Bline value
158,923contracts
12agencies
514suppliers
96.4%held by top ten

Drugs and biologicals (6505)

$15.1B
$13.2B
20242025
—of 514 suppliers
$0GRIFOLS THERAPEUTICS LLC in the line
0.0%share of the line

Agencies that buy the line and never bought from GRIFOLS THERAPEUTICS LLC

8agencies
423contracts
$51,986,752since January 2024
Department of Agriculture21 contracts
$40,416,864
Department of State233 contracts
$8,285,468
Peace Corps158 contracts
$2,977,299
Department of Homeland Security5 contracts
$127,122
Department of the Interior2 contracts
$89,569
Department of the Treasury2 contracts
$50,300
Environmental Protection Agency1 contract
$27,529
Court Services and Offender Supervision Agency1 contract
$12,600

How the line is bought

by value, since 2024
2%no competition
1%one applicant
0of these to GRIFOLS THERAPEUTICS LLC
Competed, several suppliers applied155,547 contracts
$27,183,738,963 · 96.4%
Awarded directly, no competition1,494 contracts
$630,079,768 · 2.2%
Competed, one supplier applied1,882 contracts
$393,644,990 · 1.4%

Contracts reaching their end dates

Oct 2026 – October 2027
83contracts
$634,984,156end by October 2027
22end in August 2027 · $39.5M
$11.8M
$3.8M
$4.5M
$34.2M
$2.8M
$1.4M
$38.9M
$447M
$1.2M
$39.5M
$49.6M
Oct 2620 contractsNov 269 contractsDec 265 contractsFeb 274 contractsMar 277 contractsApr 273 contractsMay 275 contractsJun 274 contractsJul 272 contractsAug 2722 contractsSep 272 contracts

Suppliers next to it in the line

since January 2024
AMERX HEALTH CARE CORP1 contract · 1 agency
$243
INDIVIOR INC.1 contract · 1 agency
$45
XELLIA PHARMACEUTICALS USA LLC1 contract · 1 agency
$42
GRIFOLS THERAPEUTICS LLC
$0

All 514 suppliers in the line

Fastest-growing supplier in the line

same line
+97%growth

Supplier UEI KABZK8W6PQT3

2024 to date
$7,051,163,185
2022–2023
$3,579,627,887

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.